AI

Showing 15 posts of 60 posts found.

Bayer and Aignostics to collaborate for AI oncology research

March 14, 2024
Research and Development AI, Bayer, Oncology, research

Bayer and Aignostics have announced that they have entered into a strategic collaboration for several artificial intelligence (AI)-powered approaches for …

Isomorphic Labs to collaborate with Eli Lilly

January 11, 2024
Research and Development AI, Eli Lilly, Isomorphic Labs, Pharmacy, drug discovery

Isomorphic Labs has announced that it has entered into a strategic research collaboration with Eli Lilly and Company, marking the …

Merck collaborates with Acceleration Consortium for AI experimentation

December 8, 2023
Research and Development AI, Acceleration Consortium, Merck, Pharmacy, experimentation

Merck and the Acceleration Consortium have announced their AI-driven experimentation planner Bayesian Back End (BayBE) is now available open-source on …

markus-spiske-hvsr_cvecvi-unsplash

Genentech and NVIDIA enter AI research collaboration

November 22, 2023
Research and Development AI, Genentech, Pharmacy, research collaboration

Genentech has announced that it has entered into a multi-year strategic research collaboration with NVIDIA that is intended to pair …

Exscientia enters AI drug discovery collaboration with Merck KGaA

September 20, 2023
Business Services AI, Exscientia, Immunology, Merck KGaA, Neurology, Oncology, collaboration, drug discovery

Exscientia has announced a new collaboration with Merck KGaA, Darmstadt, Germany, with a focus on the discovery of novel small …

NICE shares draft guidance for AI’s use in radiotherapy treatment planning

August 14, 2023
Research and Development AI, Draft Guidance, NICE, Oncology, radiotherapy

The National Institute for Health and Care Excellence (NICE) has shared draft guidance surrounding nine artificial intelligence (AI) technologies which …

Recursion and NVIDIA partner for AI-enabled drug discovery developments

July 13, 2023
Research and Development AI, Pharmacy, Recursion, drug discovery

Clinical stage biotech company Recursion has announced a $50m investment by NVIDIA, intended to accelerate the development of its AI …

Anavex Life Sciences and Partex NV Group announce AI-based strategic partnership to enhance patient experience

June 28, 2023
Research and Development AI, Anavex Life Sciences, Partex NV Group, Pharmacy, patient experience

US-based clinical-stage biopharmaceutical company Anavex Life Sciences and German digital pharma platform Partex NV Group have announced a strategic partnership …

Scientists use AI to find new antibiotic to fight superbug

May 26, 2023
Research and Development AI, Microbiology, WHO, abaucin, antibiotic resistance

Scientists at McMaster University and the Massachusetts Institute of Technology (MIT) have utilised artificial intelligence (AI) in order to discover …

pers

Personalised medicine in oncology: Where are we now?

June 30, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Cancer, oncology, presonalised medicine, surgery

The past decade has seen exponential growth in the field of oncology, with precision medicine at the forefront, driving positive …

laboratory-testing-az

Exscientia to collaborate with EQRx on drug development

June 25, 2021
Medical Communications AI, Exscientia, clinical drug development

Exscientia and EQRx have announced a strategic research and development collaboration agreement aiming to substantially accelerate the delivery of novel …

Novartis announce digital collaboration with HPE

June 24, 2021
AI, HPE, Novartis

Swiss pharma company, Novartis, has announced a collaboration with Hewlett Packard Enterprise (HPE), to accelerate its use of data and …

UK AI firm wins share of £140 million funding for lung cancer detection tech

June 18, 2021
Medical Communications AI, CT, NHS, funding, lunch cancer, screening, technology

Artificial intelligence firm Behold.ai has won a share of £140 million in government funding for its red dot lung cancer …

Exscientia buys Austrian cancer cell screening company for €50 million

June 17, 2021
AI, EU, deal, marketing, sales

UK-based AI pioneers Exscientia has announced the purchase of rival AI firm Allcyte for €50 million. The multimillion deal, paid …

1c64f360-c5ef-43b6-bcef-13cede36f571

Lucida Medical gains CE marking for AI prostate cancer tech

June 1, 2021
Manufacturing and Production AI, MRI, NHS, prostate cancer

Cambridge-based AI company, Lucida Medical, has received CE marking for its new machine learning-based prostate cancer detection software, Prostate Intelligence …

Latest content